Disclaimer: This product is not designed to diagnose, treat, cure or prevent any condition
NAD+ declines naturally with age, contributing to reduced cellular function, decreased energy production, and impaired DNA repair
We saw no change in disease progression and no such preservation of motor neurons upon liraglutide treatment
We compared the use of GLP-1RAs with second- or third-line glucose-lowering therapy to minimise confounding [22], thereby allowing us to explore the impact of including a reference group with the same disease stage, even though we adjusted for microvascular complications
Some studies in animals suggest that the peptide could accelerate bone regeneration and improve healing in bone fractures, particularly by promoting osteoblast activity (cells responsible for bone formation)
A peptide losing 50% potency effectively costs twice as much per effective dose